4.7 Article

α-RgIA, a novel conotoxin that blocks the α9α10 nAChR:: Structure and identification of key receptor-binding residues

期刊

JOURNAL OF MOLECULAR BIOLOGY
卷 377, 期 4, 页码 1216-1227

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jmb.2008.01.082

关键词

conotoxin; structure; peptide; NMR; nicotinic acetylcholine receptor

资金

  1. NIGMS NIH HHS [P01 GM048677, GM 48677, P01 GM048677-15, P01 GM048677-160012] Funding Source: Medline
  2. NIMH NIH HHS [R01 MH053631-13, R01 MH053631-11S1, R01 MH053631, R29 MH053631, MH 53631] Funding Source: Medline

向作者/读者索取更多资源

alpha-Conotoxins are small disulfide-constrained peptides from cone snails that act as antagonists at specific subtypes of nicotinic acetylcholine receptors (nAChRs). The 13-residue peptide alpha-conotoxin RgIA (alpha-RgIA) is a member of the alpha-4,3 family of alpha-conotoxins and selectively blocks the alpha 9 alpha 10 nAChR subtype, in contrast to another well-characterized member of this family, alpha-Conotoxin ImI (alpha-ImI), which is a potent inhibitor of the alpha 7 and alpha 3 beta 2 nAChR subtypes. In this study, we have altered side chains in both the four-residue and the three-residue loops of alpha-RgIA, and have modified its C-terminus. The effects of these changes on activity against alpha 9 alpha 10 and alpha 7 nAChRs were measured; the solution structures of alpha-RgIA and its Y10W, D5E, and P6V analogues were determined from NMR data; and resonance assignments were made for alpha-RgIA [R9A]. The structures for alpha-RglA and its three analogues were well defined, except at the chain termini. Comparison of these structures with reported structures of alpha-ImI reveals a common two-loop backbone architecture within the alpha-4,3 family, but with variations in side-chain solvent accessibility and orientation. Asp5, Pro6, and Arg7 in loop 1 are critical for blockade of both the alpha 9 alpha 10 and the alpha 7 subtypes. In loop 2, alpha-RgIA [Y10W] had activity near that of wild-type alpha-RgIA, with high potency for 000 and low potency for alpha 7, and had a structure similar to that of wild type. By contrast, Arg9 in loop 2 is critical for specific binding to the alpha 9 alpha 10 subtype, probably because it is larger and more solvent accessible than Ala9 in alpha-IMI. Our findings contribute to a better understanding of the molecular basis for antagonism of the alpha 9 alpha 10 nAChR subtype, which is a target for the development of analgesics for the treatment of chronic neuropathic pain. (C) 2008 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据